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BT1062 from Bacteroides thetaiotaomicron is a homolog of Mfa2 (PGN0288 or
PG0179), which is a component of the minor ﬁmbriae in Porphyromonas
gingivalis. The crystal structure of BT1062 revealed a conserved fold that is
widely adopted by ﬁmbrial components.
1. Introduction
The Gram-negative anaerobic bacterium Bacteroides thetaiotaomi-
cron is a predominant member of the mammalian intestinal micro-
biota. It is important for the study of the symbiotic relationship
between bacteria and humans, as well as for its abilities to digest
complex plant polysaccharides and host-derived polysaccharides (Xu
et al., 2003). It is also an opportunistic pathogen and can cause serious
infections. Extracellular proteins are expected to be crucial for such
functions in B. thetaiotaomicron and other gut microbes. Therefore,
we initiated a project to characterize the structures of proteins that
are speciﬁc to the gut environment from the bacterial secretome of
human gut microbiota, in order to gain further insights into the
molecular mechanisms of bacteria–host symbiosis as well as of
bacterial pathogenesis.
Here, we report the 2.2 A ˚ crystal structure of a putative ﬁmbrial
assembly protein BT1062 from B. thetaiotaomicron, which was
determined using the high-throughput pipeline of the Joint Center for
Structural Genomics (JCSG; Lesley et al., 2002) as part of the
National Institute of General Medical Sciences Protein Structure
Initiative (PSI;http://www.nigms.nih.gov/Initiatives/PSI/).TheBT1062
gene of B. thetaiotaomicron encodes a predicted lipoprotein with a
molecular weight of 36 535 Da (residues 1–317) and a calculated
isoelectric point of 4.8.
2. Materials and methods
2.1. Protein production and crystallization
Clones were generated using the Polymerase Incomplete Primer
Extension (PIPE) cloning method (Klock et al., 2008). The gene
encoding BT1062 (Swiss-Prot Q8A8V5) was ampliﬁed by polymerase
chain reaction (PCR) from B. thetaiotaomicron VPI-5482 genomic
DNA using PfuTurbo DNA polymerase (Stratagene) and I-PIPE
(Insert) primers (forward primer 50-ctgtacttccagggcGCTTCATGCG-
ACAGCTTTAATGAAGACC-30, reverse primer 50-aattaagtcgcgtta-
TTGATTCTCTTCCTGAATGCGATGCACC-30; target sequence in
upper case) that included sequences for the predicted 50 and 30 ends.
The expression vector pSpeedET, which encodes an amino-terminal
tobacco etch virus (TEV) protease-cleavable expression and puriﬁ-
cation tag (MGSDKIHHHHHHENLYFQ/G), was PCR-ampliﬁed
with V-PIPE (Vector) primers (forward primer 50-taacgcgacttaatta-
actcgtttaaacggtctccagc-30, reverse primer 50-gccctggaagtacaggttttcgt-
gatgatgatgatgatg-30). V-PIPE and I-PIPE PCR products were mixed
to anneal the ampliﬁed DNA fragments together. Escherichia coli
GeneHogs (Invitrogen) competent cells were transformed with the
I-PIPE/V-PIPE mixture and dispensed onto selective LB–agar plates.The cloning junctions were conﬁrmed by DNA sequencing. Using the
PIPE method, the gene segment encoding residues Met1–Glu22 was
deleted as it was predicted to code for a signal peptide at the start
of the protein. Expression was performed in a selenomethionine-
containing medium at 310 K with suppression of normal methionine
synthesis. At the end of fermentation, lysozyme was added to the
culture to a ﬁnal concentration of 250 mgm l
 1 and the cells were
harvested and frozen. After one freeze–thaw cycle, the cells were
sonicated in lysis buffer [50 mM HEPES pH 8.0, 50 mM NaCl, 10 mM
imidazole, 1 mM tris(2-carboxyethyl)phosphine–HCl (TCEP)] and
the lysate was clariﬁed by centrifugation at 32 500g for 30 min. The
soluble fraction was passed over nickel-chelating resin (GE Health-
care) pre-equilibrated with lysis buffer, the resin was washed with
wash buffer [50 mMHEPES pH 8.0,300 mMNaCl, 40 mM imidazole,
10%(v/v) glycerol, 1 mM TCEP] and the protein was eluted with
elution buffer [20 mM HEPES pH 8.0, 300 mM imidazole, 10%(v/v)
glycerol, 1 mM TCEP]. The eluate was buffer-exchanged with TEV
buffer (20 mM HEPES pH 8.0, 200 mM NaCl, 40 mM imidazole,
1m M TCEP) using a PD-10 column (GE Healthcare) and incubated
with 1 mg TEV protease per 15 mg of eluted protein. The protease-
treated eluate was run over nickel-chelating resin (GE Healthcare)
pre-equilibrated with HEPES crystallization buffer (20 mM HEPES
pH 8.0, 200 mM NaCl, 40 mM imidazole, 1 mM TCEP) and the resin
was washed with the same buffer.The ﬂowthrough and wash fractions
were combined and concentrated to 19.1 mg ml
 1 by centrifugal
ultraﬁltration (Millipore) for crystallization trials. BT1062 was crys-
tallized by mixing 100 nl protein solution with 100 nl crystallization
solution above a 50 ml reservoir volume using the nanodroplet vapor-
diffusion method (Santarsiero et al., 2002) with standard JCSG
crystallization protocols (Lesley et al., 2002). The crystallization
reagent consisted of 1.4 M sodium citrate, 0.1 M HEPES pH 7.5. A
cube-shaped crystal of approximate dimensions 40   40   30 mm was
harvested after 23 d at 277 K for data collection. Ethylene glycol was
added to the crystal as a cryoprotectant to a ﬁnal concentration of
10%(v/v). Initial screening for diffraction was carried out using the
Stanford Automated Mounting (SAM) system (Cohen et al., 2002)
and an X-ray microsource at Stanford Synchrotron Radiation
Lightsource (SSRL, Menlo Park, California, USA).
The oligomeric state of BT1062 in solution was determined using
a1  30 cm Superdex 200 column (GE Healthcare) coupled with
miniDAWN static light-scattering (SEC/SLS) and Optilab differential
refractive-index detectors (Wyatt Technology). The mobile phase
consisted of 20 mM Tris–HCl pH 8.0, 150 mM NaCl and 0.02%(w/v)
sodium azide. The molecular weight was calculated using ASTRA
v.5.1.5 software (Wyatt Technology).
2.2. Data collection, structure solution and refinement
Multi-wavelength anomalous diffraction (MAD) data were
collected on beamline 9-2 at the SSRL at wavelengths corresponding
to the inﬂection ( 1), high-energy remote ( 2) and peak ( 3)o fa
selenium MAD experiment. The data sets were collected at 100 K
using an MAR CCD 325 detector. The MAD data were integrated
and reduced using MOSFLM and scaled with SCALA. Selenium sites
were located using SHELXD (Sheldrick, 2008) and reﬁned using
autoSHARP (mean ﬁgure of merit of 0.46 with ten selenium sites;
Bricogne et al., 2003). Phase reﬁnement and automatic model
building were performed with RESOLVE (Terwilliger, 2003). Model
completion and reﬁnement were performed with Coot (Emsley &
Cowtan, 2004) and REFMAC (Winn et al., 2003). The reﬁnement
included experimental phase restraints in the form of Hendrickson–
Lattman coefﬁcients and TLS reﬁnement with one TLS group per
chain. CCP4 programs were used for data conversion and other
calculations (Collaborative Computational Project, Number 4, 1994).
Data-processing and reﬁnement statistics are summarized in Table 1.
2.3. Validation, deposition and figures
The quality of the crystal structure was analyzed using the JCSG
Quality Control server, which veriﬁes the stereochemical quality of
the model using AutoDepInputTool (Yang et al., 2004), MolProbity
(Lovell et al., 2003) and WHAT IF v.5.0 (Vriend, 1990), the agree-
ment between the atomic model and the data using SFCHECK
v.4.0 (Collaborative Computational Project, Number 4, 1994) and
RESOLVE (Terwilliger, 2003), the protein sequence using ClustalW
(Thompson et al., 1994), the atomic occupancies using MOLEMAN2
(Kleywegt, 2000) and the consistency of NCS pairs. It also evaluates
the differences in Rcryst/Rfree, expected Rfree/Rcryst and maximum/
minimum B values by parsing the reﬁnement log ﬁle and PDB
header. All molecular graphics were prepared with PyMOL (DeLano
Scientiﬁc). Sequence alignments were rendered using TEXshade
(Beitz, 2000).
3. Results and discussion
3.1. Sequence analysis and functional assignment
BT1062 is a member of a functionally uncharacterized protein
family [Pfam PF08842 or DUF1812 (domain of unknown function
family 1812)] consisting of  80 Bacteroidetes proteins of around 300–
structural communications
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Table 1
Summary of crystal parameters, data-collection and reﬁnement statistics for
BT1062 (PDB code 3gf8).
Values in parentheses are for the highest resolution shell.
 1 MAD-Se  2 MAD-Se  3 MAD-Se
Space group P41212
Unit-cell parameters (A ˚ ) a = 106.9, c = 79.1
Data collection
Wavelength (A ˚ ) 0.9793 0.9116 0.9792
Resolution range (A ˚ ) 29.7–2.2
(2.26–2.20)
29.6–2.2
(2.26–2.20)
29.7–2.2
(2.26–2.20)
No. of observations 98494 94479 94046
No. of reﬂections 23880 23862 23868
Completeness (%) 99.9 (99.9) 99.9 (100) 99.9 (99.8)
Mean I/ (I) 10.8 (1.8) 11.6 (2.2) 10.5 (1.6)
Rmerge on I† 0.11 (0.72) 0.10 (0.65) 0.11 (0.80)
Rmeas on I‡ 0.13 (0.82) 0.11 (0.75) 0.13 (0.93)
Model and reﬁnement statistics
Resolution range (A ˚ ) 29.2–2.2
No. of reﬂections (total) 23827
No. of reﬂections (test) 1220
Completeness (%) 99.8
Data set used in reﬁnement  2 MAD-Se
Cutoff criterion |F|>0
Rcryst§ 0.191
Rfree} 0.229
Stereochemical parameters
Restraints (r.m.s. observed)
Bond lengths (A ˚ ) 0.016
Bond angles ( ) 1.52
Average isotropic B value†† (A ˚ 2) 37.6
ESU‡‡ based on Rfree value (A ˚ ) 0.17
Protein residues/atoms 284/2321
Solvent molecules 175
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ.‡ Rmeas is the redundancy-
independent Rmerge (Diederichs & Karplus, 1997; Weiss & Hilgenfeld, 1997). § Rcryst = P
hkl
   jFobsj j Fcalcj
   =
P
hkl jFobsj, where Fcalc and Fobs are the calculated and observed
structure-factor amplitudes, respectively. } Rfree is the same as Rcryst but for 5% of the
total reﬂections chosen at random and omitted from reﬁnement. †† This value
represents the total B that includes TLS and residual B components. ‡‡ Estimated
overall coordinate error (Collaborative Computational Project, Number 4, 1994;
Cruickshank, 1999).400 residues. Homologous proteins are abundant in Bacteroidetes
genomes. For example, at least four paralogs are found in B. theta-
iotaomicron VPI-5482 (BT1062, BT2657, BT4225 and BT4226;
sequence identity of >20%), three in Porphyromonas gingivalis
(PGN0185, PGN0288 and PGN0289) and eight in B. fragilis NCTC
9343 (BF1578, BF1851, BF1976, BF2185, BF2264, BF2871, BF3328
and BF4229). The genomic context is conserved for BT1062 homo-
logs, which involves a cluster of four associated genes: BT1066,
BT1065, BT1063 and BT1062 (Fig. 1). BT1062 and BF2185 of
B. fragilis have almost identical genomic environments. A cluster of
genes BT1062–BT1068, which are likely to be an operon, all contain
signal peptides and are predicted to encode lipoproteins (with the
exception of BT1064). This putative operon may be under the control
of BT1069, which encodes a putative transcription regulator.
Downstream of the operon is a putative histidine kinase (BT1058).
BT1062 is homologous to Mfa2 (PGN0288, also previously known
as PG0179) of P. gingivalis strain ATCC 33277 (19% sequence
identity; Fig. 2a). Mfa2 co-transcribes with the minor ﬁmbrial antigen
(mfa1) and is involved in the assembly of Mfa1 ﬁmbriae (Chung et al.,
2000; Hasegawa et al., 2009). BT1063 is a remote homolog of Mfa1
(PGN0287; 15% identity; Fig. 1), which is the structural subunit of
P. gingivalis minor ﬁmbriae (Yoshimura et al., 2009). P. gingivalis also
contains homologous proteins to BT1064 and BT1066 (PGN0128 and
PGN0179; PGN0129 and PGN0178). BT1065 matches the N-terminal
domain of PGN0128, indicating that PGN0128 is a fusion product of
BT1065-like and BT1064-like proteins. Therefore, the BT1062–
BT1068 genes are most likely to encode a ﬁmbriae (or pili) system
similar to that of the minor ﬁmbriae of P. gingivalis, with BT1062
being equivalent to mfa2. P. gingivalis has at least two types of
ﬁmbriae: major (long) ﬁmbriae with FimA as the main structural
subunit (Yoshimura et al., 1984) and minor (short) Mfa1 ﬁmbriae
(Hamada et al., 1996; Park et al., 2005). Fimbriae were also observed
in strains of B. thetaiotaomicron and B. fragilis (Shinjo & Kiyoyama,
1984); however, the ﬁmbriae-assembly machinery are currently
uncharacterized at the molecular level. The similarity of the potential
ﬁmbriae proteins to those of P. gingivalis could suggest a similar
ﬁmbriae-assembly system in B. thetaiotaomicron and B. fragilis.T h e
ﬁmbriae in gut bacteria, such as B. thetaiotaomicron and B. fragilis,
may be required for adhesion to host tissues (Pumbwe et al., 2006),
formation of bioﬁlms with other bacteria in the gut, or play other as
yet unknown functional roles.
3.2. Overall structure
The selenomethionine derivative of BT1062 (residues 23–317) with
an N-terminal His tag was expressed in E. coli and puriﬁed by metal-
afﬁnity chromatography. The predicted N-terminal signal peptide
(residues 1–22) was not included in the construct. The crystal struc-
ture of BT1062 was determined in the tetragonal space group P41212
at 2.2 A ˚ resolution using the MAD method. The ﬁnal BT1062 model
includes a monomer (residues 34–317; Fig. 2b), one ethylene glycol
and 174 water molecules in the asymmetric unit. The Matthews co-
efﬁcient (VM; Matthews, 1968) for BT1062 is 3.25 A ˚ 3 Da
 1 and the
estimated solvent content is 62%. The Ramachandran plot produced
by MolProbity shows that 96.8 and 100% of the residues are in the
favored and allowed regions, respectively. BT1062 is composed of 21
 -strands ( 1– 21), three  -helices ( 1– 3) and ﬁve 310-helices. The
total  -sheet,  -helical and 310-helical contents are 43.0, 6 and 5.3%,
respectively. BT1062 is likely to exist as a monomer in solution, which
is consistent with crystal-packing analysis and analytical size-exclu-
sion chromatography.
3.3. Structural comparisons
The structure of BT1062 consists of a tandem repeat of two
domains: I (34–170) and II (171–317). Using individual domains, the
DALI structural similarity search server (Holm & Sander, 1995)
indicated that both domains have transthyretin-like (previously
known as prealbumin-like) folds with seven core  -strands (A–G)
arranged in two sheets (DAG and CBEF; Fig. 2). The top hit for
domain I is the C-terminal transthyretin subdomain of the carboxy-
peptidase D domain II (Aloy et al., 2001; PDB code 1h8l; Z = 7.0,
r.m.s.d. of 2.1 A ˚ for 78 aligned C
  atoms, 13% sequence identity). The
best match for domain II is human transthyretin (Karlsson & Sauer-
Eriksson, 2007; PDB code 2qel; Z= 6.1, r.m.s.d. of 3.6 A ˚ for 96 aligned
C
  atoms, 7% sequence identity). For the entire structure, the minor
pilin GBS52 of the Gram-positive bacterium Streptococcus agalactiae
(Krishnan et al., 2007) is among the top hits (ﬁfth), with an r.m.s.d. of
5.7 A ˚ for 145 aligned C
  atoms (PDB code 2pz4; Z = 4.1, 10%
structural communications
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Figure 1
Gene context for representative BT1062 homologs in B. thetaiotaomicron (Bth), B. fragilis NCTC 9343 (Bfs), B. vulgatus ATCC 8482 (Bvu), Parabacteroides distasonis
ATCC 8503 (Bdi) and Porphyromonas gingivalis strain ATCC 33277 (Pgn). The lengths of the genes are not drawn to scale. Each homologous set of sequences is represented
by one color.sequence identity). TM-align (Zhang & Skolnick, 2005) aligned
BT1062 to GBS52 with an r.m.s.d. of 4.8 A ˚ for 175 C
  atoms. Despite
the large r.m.s.d. value, this match is signiﬁcant since both proteins
are ﬁmbrial components. The two domains of both proteins have an
identical fold (i.e. the same topology of the seven core strands).
GBS52 does not have long inserts between core  -strands in its two
domains, except for the BC loop of the ﬁrst domain, while BT1062
contains several signiﬁcant insertions between core strands in both
domains (Fig. 2). The most signiﬁcant additional structural feature of
BT1062 is a small  -sheet at the domain boundary formed by the EF
loop of domain I and the BC loop of domain II (Fig. 3). Domain II
contains a three-helix insertion between strands F and G as well as a
 -hairpin attachment ( 20– 21) at the C-terminus. Thus, domain II
of BT1062 deviates more signiﬁcantly from the prototypical seven-
stranded core domain, although some members of the transthyretin
family have an additional  -strand that would correspond to  20. A
similar two-domain arrangement is also observed for the S. pyogenes
major pilin Spy0128 (TM-align r.m.s.d. of 5.3 A ˚ for 178 aligned C
 
atoms; Kang et al., 2007; Fig. 3). Given the overall structural similarity
and functional overlap, it seems possible that these pilin components
might be derived from a common ancestral fold through divergent
evolution. The basic fold of the seven core strands in these proteins
has previously been described as IgG-like (Krishnan et al., 2007). We
have avoided such a description here owing to a lack of clear
evidence to establish an evolutionary relationship between the IgG-
like fold (SCOP ID 48725) and the transthyretin-like fold (SCOP ID
49451) (Andreeva et al., 2004).
3.4. A conserved fold for fimbrial components
A sequence-similarity search using PSI-BLAST against the non-
redundant (nr) database at the National Center for Biotechnology
Information (NCBI) indicated that the family size of DUF1812 can
be signiﬁcantly expanded, with >1000 hits almost exclusively from
structural communications
1284 Xu et al.   BT1062 Acta Cryst. (2010). F66, 1281–1286
Figure 2
Crystal structure of BT1062. (a) Sequence alignment of BT1062, BF2185 and PGN0288 (Mfa2). The secondary-structural elements, residue numbering of BT1062 and
consensus are shown at the top. The seven conserved  -strands (A–G) of the two transthyretin-like domains are highlighted. The potential membrane-attachment site and
Mfa1-interaction site are labeled by stars at the bottom. (b) Stereo ribbon diagram of BT1062 monomer color coded from the N-terminus (blue) to the C-terminus (red).Bacteroidetes. There are 35 potential homologs from B. thetaiota-
omicron alone, indicating the popularity of this fold in this bacterium.
Interestingly, the identiﬁed homologs include components of both the
major ﬁmbriae and the minor ﬁmbriae of P. gingivalis. In addition
to the BT1062 homologs in minor ﬁmbriae discussed above, major
ﬁmbrial components, such as FimA and the accessory proteins FimC,
FimD and FimE, are expected to adopt a similar fold to BT1062.
Thus, DUF1812 is a collection of diverse proteins that are likely to be
ﬁmbrial components. These proteins are likely to be adapted from
a single fold to serve different functions. Many of these remote
homologs also contain the highly conserved tryptophan (Trp308 in
BT1062) described above.
The details of the biogenesis of Mfa1-like ﬁmbriae are still unclear.
A recent study suggested that P. gingivalis Mfa2 is likely to anchor
the Mfa1 ﬁmbriae to the outer membrane and to regulate the length
of the Mfa1 ﬁlament (Hasegawa et al., 2009). Mfa2 is present in the
outer membrane and may directly interact with Mfa1. Most sequence
homologs of BT1062 and Mfa2 contain two highly conserved
cysteines at the N-terminus (Cys25 and Cys35) located near the tip of
the bilobal molecule. The ﬁrst invariant cysteine was predicted to be
the lipoprotein signal-peptide cleavage site (between 24 and 25) by
the LipoP server (Juncker et al., 2003). This cysteine is likely to be the
last residue of the lipoprotein signal-sequence motif [lipobox motif
(L/V)XXC, X = A/S/G/T] and is directly involved in membrane
attachment of the matured lipoprotein via a thioether bond (Braun &
Wu, 1994). The role of the second conserved cysteine is currently not
clear. It may also be involved in membrane attachment owing to its
close proximity to the ﬁrst cysteine. The conformation of the peptide
between the two conserved cysteines is likely to be ﬂexible since
residues 24–33 are exposed to solvent and disordered in the crystal
with no interpretable electron density. The most conserved surface
residues of BT1062 homologs correspond to a short sequence motif
306N(G/D)W
308 located in the  20– 21 loop. This exposed site is
likely to be involved in interaction with Mfa1 and thus to be impor-
tant for the function of BT1062. The spatial arrangement of the
potential membrane-attachment site and protein–protein interaction
site may be functionally signiﬁcant as the location of the potential
membrane-attachment site would allow more freedom and accessi-
bility of a membrane-attached elongated molecule.
4. Conclusions
Bioinformatics studies, combined with experimental evidence from
the related bacteria P. gingivalis, allow us to identify at least one
structural communications
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Figure 3
Structural comparisons of (a) BT1062, (b) the minor pilin of GBS52 (PDB code 2pz4) and (c) the major pilin Spy0128 (PDB code 3b2m). All molecules are shown in a similar
orientation with the same scale. The conserved core strands are labeled from A to G.putative operon that is likely to be involved in ﬁmbrial assembly in
B. thetaiotaomicron and other related bacteria. Our structural studies
of the BT1062 protein in this operon revealed surprising structural
similarities to the minor pilin GBS52 of S. agalactiae and the major
pilin Spy0128 of S. pyogenes, both of which are Gram-positive
bacteria. We demonstrated that a tandem repeat of the transthyretin-
like fold is also likely to be adopted by other components of
Bacteroides ﬁmbriae, such as the major pili subunit FimA of
P. gingivalis. These results may suggest a common evolutionary origin
for this type of ﬁmbrial component in both Gram-negative and Gram-
positive bacteria. Thus, our studies contribute new insights into the
evolution of ﬁmbriae (pili).
Additional information about BT1062 is available from TOPSAN
(Krishna et al., 2010) at http://www.topsan.org/explore?pdbID=3gf8.
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